Detalhe da pesquisa
1.
Centrally-acting anticholinergic drugs- associations with mortality, hospitalisation and cognitive decline following dementia diagnosis in people receiving antidepressant and antipsychotic drugs.
Aging Ment Health
; 26(9): 1747-1755, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34308718
2.
Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale - a healthcare improvement study in a geriatric ward setting.
Australas Psychiatry
; 30(4): 535-540, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726508
3.
Aspirin in people with dementia, long-term benefits, and harms: a systematic review.
Eur J Clin Pharmacol
; 77(7): 943-954, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483830
4.
The anticholinergic effect on cognition (AEC) scale-Associations with mortality, hospitalisation and cognitive decline following dementia diagnosis.
Int J Geriatr Psychiatry
; 35(9): 1069-1077, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394521
5.
Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.
Int J Geriatr Psychiatry
; 32(6): 650-656, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27280553
6.
Safe prescribing of physical health medication in patients with dementia.
Int J Geriatr Psychiatry
; 29(12): 1230-41, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092795
7.
Olanzapine: a systematic review and meta-regression of the relationships between dose, plasma concentration, receptor occupancy, and response.
J Clin Psychopharmacol
; 33(3): 329-35, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23609380
8.
Managing drugs with anticholinergic activity.
Drug Ther Bull
; 61(9): 135-139, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648260
9.
Anticholinergic action is rarely a good thing.
Ther Adv Psychopharmacol
; 13: 20451253231195264, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37701892
10.
A tool for safer prescribing in vulnerable adults: the continuing development of the Medichec app and website.
BJPsych Bull
; : 1-7, 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671832
11.
Antipsychotic monitoring in dementia: quality of completion of antipsychotic monitoring forms in an older adult mental health service.
BJPsych Bull
; 46(5): 271-277, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167344
12.
Sedation-Associated Medications at Dementia Diagnosis, Their Receptor Activity, and Associations With Adverse Outcomes in a Large Clinical Cohort.
J Am Med Dir Assoc
; 23(6): 1052-1058, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122733
13.
Anticholinergic drugs and risk of dementia: Time for action?
Pharmacol Res Perspect
; 9(3): e00793, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087056
14.
Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in Dementia.
J Am Med Dir Assoc
; 22(12): 2547-2552, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473960
15.
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents.
Ther Adv Psychopharmacol
; 10: 2045125320935306, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32612804
16.
Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta-Analysis.
J Am Geriatr Soc
; 68(3): 650-658, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039479
17.
'Real time' monitoring of antipsychotic prescribing in patients with dementia: a study using the Clinical Record Interactive Search (CRIS) platform to enhance safer prescribing.
BMJ Open Qual
; 9(1)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32229485
18.
Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK.
Int J Geriatr Psychiatry
; 24(9): 944-54, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19156700
19.
Safe prescribing in cognitively vulnerable patients: the use of the anticholinergic effect on cognition (AEC) tool in older adult mental health services.
BJPsych Bull
; : 26-30, 2019 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31280737
20.
Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability.
Drugs
; 68(16): 2269-92, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18973393